Ennumo approved as Neulasta biosimilar

Drug

Ennumo · pegfilgrastim-pccg

Indication

reducing infection incidence in chemotherapy patients

FDA cleared Ennumo (pegfilgrastim-pccg) as a biosimilar to Neulasta for reducing infection incidence in chemotherapy patients.